Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2020 pubmed 14 citations

Antimicrobial peptides in human corneal tissue of patients with fungal keratitis.

Mohammed. Imran I; Mohanty. Debasmita D; Said. Dalia G DG; Barik. Manas Ranjan MR; Reddy. Mamatha M MM; Alsaadi. Ahmed A; Das. Sujata S; Dua. Harminder Singh HS; Mittal. Ruchi R

Key Findings

  • All measured antimicrobial peptides (AMPs) were significantly up‑regulated in active fungal keratitis samples
  • HBD‑1 and HBD‑2 showed the most consistent increase (18/20 eyes)
  • LL‑37 showed only moderate up‑regulation in 7 out of 20 eyes and returned to baseline after healing

Practical Outcomes

  • For DIY health enthusiasts, the data suggest LL‑37 isn’t a key player in fighting fungal eye infections, so targeting it isn’t likely to improve outcomes. Efforts might be better spent on other AMPs or broader antifungal strategies rather than trying to boost LL‑37 levels.

Summary

The study looked at natural antimicrobial proteins in the eyes of people with fungal infections. It found that most of these proteins were higher during infection, especially HBD‑1 and HBD‑2, while LL‑37 was only modestly increased in a few cases and dropped back to normal after healing.

Abstract

Fungal keratitis (FK) is the leading cause of unilateral blindness in the developing world. Antimicrobial peptides (AMPs) have been shown to play an important role on human ocular surface (OS) during bacterial, viral and protozoan infections. In this study, our aim was to profile a spectrum of AMPs in corneal tissue from patients with FK during the active pase of infection and after healing. OS samples were collected from patients at presentation by impression cytology and scraping. Corneal button specimens were collected from patients undergoing therapeutic penetrating keratoplasty for management of severe FK or healed keratitis. Gene expression of human beta-defensin (HBD)-1, -2, -3 and -9, S100A7, and LL-37 was determined by quantitative real-time PCR. Messenger RNA expression (mRNA) for all AMPs was shown to be significantly upregulated in FK samples. The levels of HBD-1 and -2 mRNA were found to be elevated in 18/20 FK samples. Whereas mRNA for HBD-3 and S100A7 was upregulated in 11/20 and HBD9 was increased in 15/20 FK samples. LL-37 mRNA showed moderate upregulation in 7/20 FK samples compared with controls. In healed scar samples, mRNA of all AMPs was found to be low and matching the levels in controls. AMP expression is a consistent feature of FK, but not all AMPs are equally expressed. HBD-1 and -2 are most consistently expressed and LL-37 the least, suggesting some specificity of AMP expression related to FK. These results will help to identify HBD sequence templates for designing FK-specific peptides to test for therapeutic potential.

Study Information

Provider

pubmed

Year

2020

Date

2020-08-27T00:00:00.000Z

DOI

10.1136/bjophthalmol-2020-316329

Citations

14

References

47